🇺🇸 FDA
Pipeline program

Multi-component Interventions

CAMS&PUMC-IEC-2024-043

Unknown other active

Quick answer

Multi-component Interventions for Multimorbidity is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Multimorbidity
Phase
Unknown
Modality
other
Status
active

Clinical trials